---
title: "Nature揭示肺腺癌上皮细胞状态和可塑性图谱"
date: 2024-05-20T04:04:35Z
draft: ["false"]
tags: [
  "fetched",
  "生信人"
]
categories: ["Acdemic"]
---
Nature揭示肺腺癌上皮细胞状态和可塑性图谱 by 生信人
------
<div><p><img data-galleryid="" data-imgfileid="503745034" data-ratio="0.3274582560296846" data-src="https://mmbiz.qpic.cn/mmbiz_gif/N3X4LBoaQjU9abk37Q6pRd9QUqmbgwBYMLh9SImibmH2QJhYav5XWHhgxw9GuyLIXqOmyasZ5njzHdvEreJazxg/640?wx_fmt=gif&amp;from=appmsg" data-type="gif" data-w="1078" src="https://mmbiz.qpic.cn/mmbiz_gif/N3X4LBoaQjU9abk37Q6pRd9QUqmbgwBYMLh9SImibmH2QJhYav5XWHhgxw9GuyLIXqOmyasZ5njzHdvEreJazxg/640?wx_fmt=gif&amp;from=appmsg"></p><section><span><span>了解早期肺腺癌</span><span>(lung adenocarcinoma</span><span>，</span><span>LUAD)</span><span>发生</span><span>发展的</span><span>病理生理</span><span>过程</span><span>对于早期</span><span>制定干预策略</span><span>至关重要，今天给各位介绍这一篇近期发表在</span><em><span>Nature</span></em><span>上的文章，该团队</span><span><span>研究了来自</span>16<span>例早期</span></span><span>LUAD</span><span><span>和</span>47<span>例匹配的正常肺样本的单个上皮细胞。上皮细胞包括多种正常和癌细胞状态，</span></span><span>通过对癌细胞特异的转录特征分析，从而发现预防和干预的潜在靶点</span><span>。</span><span>究竟怎么样，我们一起看看吧！</span><span><p></p></span></span></section><section><span><p><img data-galleryid="" data-imgfileid="503746041" data-ratio="0.37326073805202664" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFvWDxudzzf58qQQX9l5GFmkVHqJogS2yuVET6XB7BDSGe8wJvsyLXnXSHXKk3IHwxWZhs3uEnDw/640?wx_fmt=png&amp;from=appmsg" data-type="jpeg" data-w="1653" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFvWDxudzzf58qQQX9l5GFmkVHqJogS2yuVET6XB7BDSGe8wJvsyLXnXSHXKk3IHwxWZhs3uEnDw/640?wx_fmt=png&amp;from=appmsg"></p></span><span>标题：</span><strong><span>An atlas of epithelial cell states and plasticity in lung adenocarcinoma</span></strong></section><section><span><span>期刊：</span><span><strong><em><span>Nature</span></em><span><span>（中科院</span><span>1</span><span>区 </span></span><span>IF</span><span><span>：</span><span>64.8</span><span>）</span></span></strong></span><span></span><span><p></p></span></span></section><section><span><span>PMID: 38418883</span><span>   </span><span>DOI: 10.1038/s41586-024-07113-9</span></span></section><section><span><br></span></section><section><span><strong><span><span>一、</span><strong><span>研究背景</span></strong></span></strong></span></section><section><span><span><span>由于早期筛查的普及，</span><span>LUAD</span></span><span>越来越多地在早期病理阶段被发现。然而，患者预后仍然是中等到较差的，因此需要改进早期治疗策略。解码驱动</span><span>LUAD</span><span>的</span><span>早期事件</span><span>可以确定理想</span><span>八靶点</span><span><span>。先前的研究表明，吸烟导致普遍的分子</span>(<span>例如</span><span>KRAS</span><span>突变</span><span>)</span><span>和免疫变化，这些变化在</span></span><span>LUAD</span><span><span>及其相邻的正常系统之间共享，并且与肺恶性病变和</span>LUAD<span>的发展密切相关。</span></span><span>然而</span><span>，特异性上皮</span><span>细胞</span><span><span>亚群或它们如何促进损伤领域，触发正常肺</span>(NL)<span>向癌前病变的进展以及促进</span><span>LUAD</span><span>发病机制尚不清楚。</span></span><span>因此，</span><span><span>了解</span>LUAD<span>起始的细胞类型特异性变化将有助于确定预防这种病态疾病的可行靶点和策略</span></span><span>。</span></span></section><section><span><br></span></section><section><span><strong><span>二、实验结果</span></strong></span></section><section><span><strong><span><p><img data-galleryid="" data-imgfileid="503746042" data-ratio="0.753125" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_jpg/N3X4LBoaQjVFvWDxudzzf58qQQX9l5GFWAweIphzxDusCatmK40biaq8DLhibR1HIIGvzjGHn9VJw6Zt0bxxJtPQ/640?wx_fmt=jpeg&amp;from=appmsg" data-type="jpeg" data-w="1280" src="https://mmbiz.qpic.cn/mmbiz_jpg/N3X4LBoaQjVFvWDxudzzf58qQQX9l5GFWAweIphzxDusCatmK40biaq8DLhibR1HIIGvzjGHn9VJw6Zt0bxxJtPQ/640?wx_fmt=jpeg&amp;from=appmsg"></p></span></strong></span></section><section><span>图1.正常肺上皮和早期LUAD中恶性亚群的分析。</span><p></p></section><section><br></section><section><span><span>1</span>、肺上皮细胞转录组全景观</span><span><p></p></span></section><section><span><span>该团队结合了对早期</span><span>LUAD<span>临床标本的深入</span><span>sc</span></span><span>RNA</span><span><span>测序，以及对暴露于烟草致癌物后</span>LUAD<span>发展的人类相关模型的跨物种分析和谱系追踪</span><span>(</span><span>图</span></span><span>1</span><span>a)<span>。使用</span><span>scRNA-seq</span><span>研究了来自富含</span></span><span><span>EPCAM</span><span>的</span></span><span>16</span><span>例</span><span><span>早期</span>LUAD<span>患者样本和</span><span>47</span></span><span>例</span><span>NL<span>样本的上皮细胞亚群，这些样本跨越了</span><span>LUAD</span><span>的地形连续体，即肿瘤邻近、肿瘤中间和肿瘤远端位置</span><span>15(</span><span>图</span></span><span>1</span><span>a)<span>。</span></span><span>此外</span><span><span>还收集了来自同一区域的肿瘤和正常组织集，用于全外泌子组测序</span>(WES)<span>分析和高分辨率空间转录组学</span><span>(ST)</span><span>和蛋白质分析</span><span>(</span><span>图</span></span><span>1</span><span>a)<span>。</span></span><span>质控后保留</span><span>246102<span>个上皮细胞进行分析。通过整合来自推断拷贝数变异（推断</span><span>CN</span></span><span>V</span><span><span>）、聚类分布、谱系特异性基因表达和携带</span>KRAS</span><sup><span>G12</span></sup><span><span>体细胞突变的读数的存在信息，将恶性细胞（</span>n=17064<span>）与其他非恶性正常细胞（</span><span>n=229038</span><span>）区分开来（图</span></span><span>2</span><span>b<span>）。</span></span><span>恶性细胞形成了</span><span>14<span>个簇（图</span></span><span>1</span><span>c<span>），这些簇主要是患者特异性的，这意味着强烈的患者间异质性。</span></span></span></section><section><span><p><p><img data-galleryid="" data-imgfileid="503746043" data-ratio="1.0538267451640033" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_jpg/N3X4LBoaQjVFvWDxudzzf58qQQX9l5GFssF088SfibZY0oz9p666fuLVyEJNCaZHnBiblic8OT5ia0cspxT1jGjdXQ/640?wx_fmt=jpeg&amp;from=appmsg" data-type="jpeg" data-w="1189" src="https://mmbiz.qpic.cn/mmbiz_jpg/N3X4LBoaQjVFvWDxudzzf58qQQX9l5GFssF088SfibZY0oz9p666fuLVyEJNCaZHnBiblic8OT5ia0cspxT1jGjdXQ/640?wx_fmt=jpeg&amp;from=appmsg"></p></p></span></section><section><span>图2. 人类LUAD中KACs的鉴定和表征。</span><span><span><p></p></span></span></section><section><span><span><span><br></span></span></span></section><section><span>2、LUAD恶性转录程序</span><span><span><p></p></span></span></section><section><span><span><span>与</span>EGFR<span>突变</span><span>LUADs (EM-LUADs)</span><span>或</span><span>MET</span><span>突变</span><span>LUADs (MM-LUADs)</span><span>的恶性细胞明显不同</span><span>(</span><span>图</span><span>1e)</span></span><span><span>，</span><span>KM</span></span><span> - </span><span><span>LUAD</span> (</span><span>KRAS wild-type</span><span> <span>- LUAD)</span></span><span><span>在样本和细胞水平上表现出更多的转录组相似性</span>(<span>即更短的</span><span>Bhattacharyya</span><span>距离</span><span>)</span></span><span>。总体而言，携带</span><span>KRAS</span><sup><span>G12D</span></sup><span><span>突变的恶性细胞显示出分化减少，这与</span>KM </span><span>- </span><span>LUAD<span>中肺泡分化（</span><span>MP31</span><span>）的丧失一致。</span></span><span>其中，</span><span><span>来自患者</span>P14<span>的恶性细胞簇表现出不同水平的</span><span>CNVs 15</span><span>，其中富含</span><span>KRAS </span></span><sup><span>G12D</span></sup><span><span>细胞簇携带相对较晚的</span>CNV<span>事件（例如，染色体</span><span>1p</span><span>缺失、染色体</span><span>8</span><span>和染色体</span><span>12</span><span>增加）和肺泡特征评分降低，这与减弱的分化一致（扩展数据图</span><span>2g</span><span>，</span><span>h</span><span>）。</span><span>KRAS</span><span>特征是基于队列中</span><span>KRAS</span><span>突变恶性细胞的不同表达特征得出的，其与</span><span>MP30</span><span>特征强</span></span><span>烈且</span><span>显</span><span>著相关。</span><span><p></p></span></span></section><section><span><span><span><br></span></span></span></section><section><span>3、LUAD中的AICs</span><span><span><p></p></span></span></section><section><span><span><span>与多区域</span>NL<span>样本相比，</span><span>LUAD</span><span>中的</span><span>AT2</span><span>细胞总体减少（</span><span>P=0.002</span><span>），</span></span><span>而</span><span>AICs<span>显示出相反的模式（</span><span>P=0.02</span><span>；扩展数据图第</span><span>3a</span><span>、</span><span>b</span><span>段）。</span><span>AT2</span><span>细胞在</span><span>7</span><span>名患者的多区域</span><span>NL</span><span>样本中，随着肿瘤接近度的增加</span></span><span>而</span><span><span>逐渐减少（</span>P=0.004<span>）。</span><span>AICs</span></span><span>是</span><span>AT2-AT1<span>细胞的发育和分化轨迹</span></span><span>中的中介</span><span><span>（图</span>2a<span>）。</span><span>LUAD</span><span>组织中分化程度最低的</span><span>AICs</span><span>的比例高于分化程度较高的</span><span>AICs</span><span>（分别为</span><span>29%</span><span>和</span><span>11%</span><span>）。值得注意的是，</span><span>AICs</span><span>被推断为向恶性细胞过渡，包括</span><span>KRAS</span><span>突变细胞，其相对于</span><span>EGFR</span><span>突变恶性细胞发育更晚（</span><span>P</span><span>＜</span><span>2.2×10</span></span><sup><span>−16</span></sup><span><span>；图</span>2a<span>）。对</span><span>AICs</span><span>的进一步分析确定了具有明显高表达</span><span>KRT8</span><span>的亚群（图</span><span>2b</span><span>）。这些</span><span>KACs</span><span>具有增加的</span><span>CDKN1A</span><span>、</span><span>CDKN2A</span><span>、</span><span>PLAUR</span><span>和肿瘤标记物</span><span>CLDN4</span><span>的表达（图</span><span>2b</span><span>）。</span><span>KACs</span><span>分化程度也明显较低（</span><span>P</span><span>＜</span><span>2.2×10</span></span><sup><span>−16</span></sup><span><span>；图</span>2c<span>），发育较晚（</span><span>P</span><span>＝</span><span>1.2×10</span></span><sup><span>−11</span></sup><span><span>）。值得注意的是，</span>KACs<span>转变为</span><span>KRAS</span><span>突变的恶性细胞，而其他</span><span>AICs</span><span>与向</span><span>AT1</span><span>细胞的分化更密切相关。相对于多区域</span><span>NL</span><span>组织，</span><span>LUAD</span><span>中非恶性上皮细胞中</span><span>KACs</span><span>的比例显著增加（</span><span>P=2.4×10</span></span><sup><span>−4</span></sup><span><span>；图</span>2d<span>），且</span><span>LUAD</span><span>中</span><span>KACs</span><span>显著高于</span><span>AT1</span><span>、</span><span>AT2</span><span>或其他</span><span>AIC</span><span>组分（</span><span>P&lt;2.2×10</span></span><sup><span>−16</span></sup><span><span>；图</span>2e<span>）。</span></span><span>来自患者</span><span>P14<span>的肿瘤组织的</span><span>ST</span><span>分析显示，</span><span>KRT8</span><span>在肿瘤区域（具有高</span><span>CNV</span><span>评分）和组织学上包括高反应性肺细胞并表现出中到低</span><span>CNV</span><span>评分的</span><span>TAN</span><span>区域中的表达增加（图</span><span>2g</span><span>）。</span></span><span>且</span><span><span>相对于肺泡细胞，</span>KACs<span>更接近肿瘤区域。</span><span>KAC</span><span>富集区的</span><span>ST</span><span>分析表明，</span><span>KAC</span><span>在肺泡实质向肿瘤细胞的转变中起中介作用。肿瘤区域</span><span>NKX2-1</span><span>的表达和肺泡特征显著减少（扩展数据图</span><span>4b</span><span>），这与</span><span>KM </span></span><span>- </span><span>LUAD<span>中肺泡分化减少一致。</span><span>KAC</span><span>标记物（图</span><span>2b</span><span>）在肿瘤区域和具有反应性肺细胞的</span><span>TAN</span><span>中较高，并且它们在空间上与</span><span>KRAS</span><span>特征重叠（图</span><span>2g</span><span>）。相反，其他</span><span>AIC</span><span>与</span><span>KRAS</span><span>（</span><span>R=0.045</span><span>；</span><span>P=3.2×10−5</span><span>）或肺泡（</span><span>R=−0.11</span><span>；</span><span>P&lt;2.2×10−16</span><span>）特征之间没有相关性。</span></span><span>总而言之，该团队研究结果表明</span><span>KACs</span><span>是</span><span><span>一种与人类</span>LUAD<span>，特别是</span><span>KM-LUAD</span><span>的发病机制高度相关的中间肺泡细胞亚群。</span></span></span></section><section><span><p><img data-galleryid="" data-imgfileid="503746044" data-ratio="0.52578125" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_jpg/N3X4LBoaQjVFvWDxudzzf58qQQX9l5GFiadmZkv3M8H5RkVwJGkKAdypRYiaWB2e2XkdicyX21em0108ZTTtPibazw/640?wx_fmt=jpeg&amp;from=appmsg" data-type="jpeg" data-w="1280" src="https://mmbiz.qpic.cn/mmbiz_jpg/N3X4LBoaQjVFvWDxudzzf58qQQX9l5GFiadmZkv3M8H5RkVwJGkKAdypRYiaWB2e2XkdicyX21em0108ZTTtPibazw/640?wx_fmt=jpeg&amp;from=appmsg"></p></span></section><section><span>图3. KAC 在烟草相关 KM-LUAD 发病机制中早期和肿瘤发病前的演变</span><span><span><p></p></span></span></section><section><span></span></section><section><br></section><section><span>4、一种与小鼠KM-LUAD有关的KAC状态</span><span><p></p></span></section><section><span><span>接着对来自小鼠的肺上皮细胞进行了</span></span><span>scRNA-seq</span><span><span><span>分析，其中肺谱系特异性</span>G蛋白偶联受体a基因Gprc5a被敲除（Gprc5a</span><sup><span>-</span></sup><sup><span>/</span></sup><sup><span>-</span></sup><span>）后<span>，在烟草致癌物暴露后产生</span>KM LUAD。在暴露结束时（EOE）和暴露后7个月，即KM-LUAD发作的时间点用尼古丁衍生的亚硝胺酮（NNK）或生理盐水（作为对照）处理的Gprc5a</span><sup><span>-</span></sup><sup><span>/</span></sup><sup><span>-</span></sup><span><span>小鼠的肺。聚类分析揭示了不同的谱系，包括聚集在</span>AT1和AT2细胞亚群之间并靠近肿瘤细胞的KACs。与人类细胞相似，恶性细胞表现出谱系特异性基因的低表达。同样，<span>来自恶性集群的细胞具有高</span>CNV评分，表达KRAS </span><sup><span>G12D</span></sup><span><span>突变，并显示出与肺泡分化丧失（</span>Kng2和Meg3）和免疫抑制（Cd24a）相关的标记物表达增加。<p></p></span></span></section><section><br></section><section><span><span>获得的小鼠KAC特征在小鼠KACs和恶性细胞(P &lt; 2.2 × 10</span><sup><span>-16</span></sup><span>)和人LUAD (P = 1.2 × 10</span><sup><span>-8</span></sup><span>)中显著丰富，在癌前AAHs (P = 4.3 × 10</span><sup><span>-4</span></sup><span>)中也显著增加，相对于匹配的NL组织，侵袭性LUAD (P = 1.5 × 10</span><sup><span>-</span></sup><sup><span>3</span></sup><span>)进一步增加。<p></p></span></span></section><section><br></section><section><span><span>于是该团队对队列中的细胞与来自两项独立研究的KRAS</span><sup><span>G12D</span></sup><span><span>驱动的细胞进行了整合的</span>scRNA-seq分析。簇C5包括来自所有三项研究的细胞，具有明显高表达的KAC标记物和KAC特征本身。与正常AT2细胞相比，来自KRAS</span><sup><span>G12D</span></sup><span><span>驱动的小鼠的</span>C5细胞仍然表达更高水平的KAC特征。与这些发现一致，小鼠KAC特征与其人类对应物一样，相对于EM - LUAD，KM <span>-</span> LUAD的KAC和恶性细胞中显著富集（分别为P=0.04和P&lt;2.2×10</span><sup><span>-</span></sup><sup><span>16</span></sup><span>）。<p></p></span></span></section><section><br></section><section><span><span><span>接着为了进一步揭示KACs的生物学特征，该团队发现</span>GFP</span><sup><span>+</span></sup><span><span>类器官在</span>KACs中富集。GFP</span><sup><span>+</span></sup><span><span>细胞（</span>n=3089）几乎完全由AT2、早期肿瘤和AT2样肿瘤细胞、KACs和KAC样细胞以及少数AT1细胞组成，所有这些细胞在GFP</span><sup><span>-</span></sup><span>组分中几乎不存在。与早期AT2样肿瘤细胞相比，从这个时间点开始的GFP</span><sup><span>+</span></sup><span>KACs，与癌前的形成相吻合，在相似的部分携带驱动因子KRAS</span><sup><span>G12D</span></sup><span>突变。最后，该团队利用KRAS（G12D）抑制剂<span>联合Cre工具鼠，最终确定</span>KACs是KM-LUAD早期发展和烟草致癌物暴露后的中间细胞状态。</span></span></section><section><span><p><img data-galleryid="" data-imgfileid="503746046" data-ratio="1.0179885527391659" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_jpg/N3X4LBoaQjVFvWDxudzzf58qQQX9l5GFYek36YBIDbnKnwKsW8ljOJHNmicAgcbR4rsw9Gz935zibiac5qI7Da1dQ/640?wx_fmt=jpeg&amp;from=appmsg" data-type="jpeg" data-w="1223" src="https://mmbiz.qpic.cn/mmbiz_jpg/N3X4LBoaQjVFvWDxudzzf58qQQX9l5GFYek36YBIDbnKnwKsW8ljOJHNmicAgcbR4rsw9Gz935zibiac5qI7Da1dQ/640?wx_fmt=jpeg&amp;from=appmsg"></p></span></section><section><span><span>图</span><span>4</span><span> KACs<span>与</span>AT2<span>向</span>K</span><span>RAS</span><span>突变肿瘤细胞的转变有关</span></span></section><section><span><br></span></section><section><span><strong><span>三、讨论</span></strong></span></section><section><span><span>该团队通过对早期</span><span>LUAD<span>肺的上皮细胞进行了多模式分析，发现了与</span>KM-LUAD<span>发病机制有关的多种恶性状态、</span>ITH<span>模式和细胞可塑性程序。其中，鉴定了肺泡分化程序激活后产生的肺泡中间细胞（</span><span>KACs</span><span>），它可以作为</span><span>KM-LUAD</span><span>的祖细胞。</span><span>KACs</span><span>在小鼠和患者样本中病变附近的正常出现区域都很明显，这表明这些细胞的早期出现可能代表</span></span><span>“</span><span>损伤场</span><span>”</span><span>。一个与人类癌症的发展和正常肺组织中存在的复杂突变谱有关</span><span>的“损伤场”。这揭示了</span><span>KACs<span>和</span><span>KRAS</span><span>突变的肺肿瘤细胞之间的紧密联系和密切共享的特性，包括</span><span>KRAS</span><span>突变、分化减少和途径。</span></span><span>结合对早期人类</span><span>LUAD<span>和</span><span>K</span></span><span>RAS</span><span><span>突变肺癌模型的深入研究，提供了一个具有大量上皮细胞的图谱。这张人类和小鼠肺中上皮和恶性细胞状态的图谱强调了</span>LUAD<span>开始的新的细胞特异性亚群</span></span><span>，这</span><span><span>可能会启发目标的推导（例如，早期</span>KRAS</span><span>程序</span><span><span>等</span>KAC<span>信号），以防止</span><span>LUAD</span><span>的启动和发展。</span></span><span><p></p></span></span></section><section><br></section><section><span><strong><span>四、总结</span></strong></span><span><strong><span><p></p></span></strong></span></section><section><span><span>这篇</span><em><span>Nature</span></em><span>文章通过对来自</span><span>16</span><span>例早期</span><span>LUAD</span><span>的肺上皮细胞进行</span></span><span>转录组学</span><span><span>分析，确定了</span><span>KM-LUAD</span><span>密切</span><span>相关的细胞状态，最终确定了KACs是KM-LUAD早期发展和烟草致癌物暴露后的中间细胞状态，为未来早期预防和介入提供了潜在靶点。更多详情还请大家移步原文，仔细品鉴。</span></span><span><p></p></span></section><p><br></p><p><span><strong>更多个性化方案设计</strong></span></p><p><span><strong>扫码领取</strong></span></p><p><img data-cropselx1="0" data-cropselx2="238" data-cropsely1="0" data-cropsely2="211" data-imgfileid="503746049" data-ratio="0.9811738648947951" data-src="https://mmbiz.qpic.cn/mmbiz_jpg/N3X4LBoaQjXGEqnFwdrCTFhibYEjDbvpjASdclY6sQoQ6UiaGsb19NWGeiaTzKibr2qUtDtOcYFVuF8R3HOlc5RuIw/640?wx_fmt=jpeg&amp;from=appmsg" data-type="jpeg" data-w="903" data-width="150px" src="https://mmbiz.qpic.cn/mmbiz_jpg/N3X4LBoaQjXGEqnFwdrCTFhibYEjDbvpjASdclY6sQoQ6UiaGsb19NWGeiaTzKibr2qUtDtOcYFVuF8R3HOlc5RuIw/640?wx_fmt=jpeg&amp;from=appmsg"></p><p><strong>适合临床医生的科研方案</strong></p><p><strong><br></strong></p><section data-tools="135编辑器" data-id="136209" data-color="#00259f"><section><section><section><section><section><section><br></section><section><br></section></section><section><section><br></section><section><br></section></section></section><section><strong>最新文章汇总</strong><span>（持续更新ing）</span></section></section><section data-width="100%"><br></section></section><section><section><section><section><br></section></section><section data-width="100%"><section><span><strong data-brushtype="text"><strong><span>最新热点方向</span></strong></strong></span></section></section></section><section><section data-autoskip="1"><p><span>1、<a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651229281&amp;idx=2&amp;sn=7f80405e8d2b40aa69f2658e9da9183d&amp;chksm=8b5f8b0ebc28021849b172672cd4fc89309f4997537ad283f9a47dff119e2af19c3c4f2e4f92&amp;scene=21#wechat_redirect" textvalue="今天开心，安利一个超好发版干湿结合思路" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="2">今天开心，安利一个超好发版干湿结合思路</a></span></p><p><span>2、</span><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651229282&amp;idx=4&amp;sn=60bbb2c5ae38b362ff1a7e5a8e80bf3c&amp;chksm=8b5f8b0dbc28021bb15e7b948b1ec5d06a2c60388b00fd50368948e8d0ce5ffca2335ab75ff8&amp;scene=21#wechat_redirect" textvalue="掌握孟德尔随机化发20分不是梦" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="2">掌握孟德尔随机化发20分不是梦</a></p><p><span>3、</span><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651229280&amp;idx=1&amp;sn=eca04f7905098b44749e53c5cebe0076&amp;chksm=8b5f8b0fbc280219f1ebcdde8ce58d0993965baaf01d05461882d08bbf07ae2eef8242d1f242&amp;scene=21#wechat_redirect" textvalue="研究中草药难发SCI？" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="2">研究中草药难发SCI？</a></p><p><span>4、</span><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651229264&amp;idx=6&amp;sn=fe295c172ae11bff98867fb5e83264aa&amp;chksm=8b5f8b3fbc2802290a72d4c5d3bfe2c82e7d53d90c781b42cc0c02ea3c8acecc2de2e6b6551d&amp;scene=21#wechat_redirect" textvalue="公开数据纯分析发7+，内容不卷赢在选题" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="2">公开数据纯分析发7+，内容不卷赢在选题</a></p><p><span>5、</span><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651229264&amp;idx=2&amp;sn=9154686fece39cb6a3d1072a06aac041&amp;chksm=8b5f8b3fbc280229fba49f3ef98e79ec84a770d14fdd2ac716c5ffd6077fab6bf5d6a8456ae5&amp;scene=21#wechat_redirect" textvalue="人手一篇的“淋巴转移”，摇身一变50+" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="2">人手一篇的“淋巴转移”，摇身一变50+</a></p></section></section></section><section><section><section><section><br></section></section><section data-width="100%"><section><span><strong data-brushtype="text"><strong><span>生信人课堂</span></strong></strong></span></section></section></section><section><section data-autoskip="1"><p><span>1、</span><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651228970&amp;idx=7&amp;sn=1310dc5fcd181d48020b801f55e97863&amp;chksm=8b5f8c45bc28055319cd1bbd3a400fdc4385d4ad469f62b530356a24c711b44a61a4cfd918c0&amp;scene=21#wechat_redirect" textvalue="临床医生科研规划" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="2">临床医生科研规划</a></p><p><span>2、</span><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651229044&amp;idx=3&amp;sn=91fc8d9347393a7bfce9c1a030728334&amp;chksm=8b5f8c1bbc28050da00f8ed43168999dd8791d13e699641cd4d75c23a2a809db0c98bb2bc5f3&amp;scene=21#wechat_redirect" textvalue="热点基因集预后实操课程" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="2">热点基因集预后实操课程</a></p><p><span>3、</span><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651229206&amp;idx=3&amp;sn=d2900b86cd4bc6f452702b444fc278ae&amp;chksm=8b5f8b79bc28026faed6a6ed29566641aca7fc8fe4c6291bfe41901ec49dfc362939886ca6a0&amp;scene=21#wechat_redirect" textvalue="孟德尔随机与基因组" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="2">孟德尔随机与基因组</a></p><p><span>4、</span><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651215654&amp;idx=3&amp;sn=02efc087cdc07e2da0526468a21bac9d&amp;chksm=8b5f5049bc28d95f77b9d128be607bfc76884483247f5f844827965f0b416aaa44fd6ef56533&amp;scene=21#wechat_redirect" textvalue="R语言入门" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="2">R语言入门</a></p><p><br></p><p><a href="http://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651228874&amp;idx=6&amp;sn=e2c9030b187c654d7faf43f9ae16fa0e&amp;chksm=8b5f8da5bc2804b3a02f80ebe48b9d26cc95b395cc6a955b53b0fd97a996653dd4ed4cc37e08&amp;scene=21#wechat_redirect" data-linktype="2">课题设计</a><span> | <a href="http://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651223612&amp;idx=6&amp;sn=6c1d6704031c8bf69ecc76742b34518e&amp;chksm=8b5f7153bc28f8456c411f5b04b012c4596c2d39e3719a2c9fdd554e8adbe734fb552106fafb&amp;scene=21#wechat_redirect" data-linktype="2">生信分析</a> | <a href="http://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651228415&amp;idx=2&amp;sn=2c65d74e35632ce52094d25e0d2fcf33&amp;chksm=8b5f8f90bc2806866eb21d5e78bc339cdec20a0a08cff9a8e9bd7829bc0cea9616bccd421f1b&amp;scene=21#wechat_redirect" data-linktype="2">数字产品</a></span></p><p><span>概普生物 让科研丰富</span></p><section data-tools="135编辑器" data-id="125822" data-color="#00259f"><section data-bgw="266" data-ratio="0.8421052631578947"><section data-width="40%"><section><img data-imgfileid="503746048" data-ratio="1" data-src="https://mmbiz.qpic.cn/mmbiz_jpg/N3X4LBoaQjU9pVqybklYdEKFjZficQAkyriaFLg29vYZVE0lNNOzrth1dv4yKZ6qg7J5zOvIibu3kYgaMZWxxo1Yg/640?wx_fmt=jpeg&amp;from=appmsg" data-type="jpeg" data-w="258" data-width="100%" src="https://mmbiz.qpic.cn/mmbiz_jpg/N3X4LBoaQjU9pVqybklYdEKFjZficQAkyriaFLg29vYZVE0lNNOzrth1dv4yKZ6qg7J5zOvIibu3kYgaMZWxxo1Yg/640?wx_fmt=jpeg&amp;from=appmsg"></section></section><section data-width="60%"><section><section><section><strong data-brushtype="code">生信人</strong></section><section><section><br></section></section></section></section><section>专注于基因技术相关知识分享</section><section>扫码关注 获取更多</section></section></section></section><p><br></p><p><br></p><section data-tools="135编辑器" data-id="118316" data-color="#00259f"><section><section><section><p><br></p><section><br></section><p><br></p></section><section><strong data-brushtype="text">END</strong></section><section><section><br></section></section></section></section></section></section></section></section></section></section><p><br></p><p><mp-style-type data-value="3"></mp-style-type></p></div>  
<hr>
<a href="https://mp.weixin.qq.com/s/IbyWRWy30qWE90Y4e1EpXw",target="_blank" rel="noopener noreferrer">原文链接</a>
